Kolon Life Science Inc. (KOSDAQ:102940)

South Korea · Delayed Price · Currency is KRW

63,800

-1,200 (-1.85%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Chemical Business Division	158.78B	124.38B	145.47B	164.40B	155.03B
Chemical Business Division Growth	27.65%	-14.50%	-11.51%	6.04%	-
Bio Business Division	2.61B	254.86M	16.11B	1.09B	-25.62B
Bio Business Division Growth	922.46%	-98.42%	1384.13%	-	-
Total	161.39B	124.64B	161.58B	165.49B	129.41B
Total Growth	29.48%	-22.86%	-2.36%	27.87%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Korea	28.86B	16.54B	19.92B	45.33B	39.58B
Korea Growth	74.45%	-16.94%	-56.06%	14.54%	-
Japan	68.28B	62.68B	74.64B	76.82B	51.07B
Japan Growth	8.95%	-16.02%	-2.84%	50.43%	-
Europe	10.69B	7.28B	10.94B	6.66B	7.56B
Europe Growth	46.80%	-33.45%	64.15%	-11.88%	-
Asia/Pacific	37.86B	28.15B	48.75B	33.64B	26.54B
Asia/Pacific Growth	34.49%	-42.27%	44.91%	26.75%	-
Other	15.70B	9.99B	7.34B	3.02B	4.66B
Other Growth	57.13%	36.15%	142.75%	-35.15%	-
Total	161.39B	124.64B	161.58B	165.49B	129.41B
Total Growth	29.48%	-22.86%	-2.36%	27.87%	-

Source: S&P Global Market Intelligence.